SCHEMBL3833549

SCHEMBL3833549

CCc1c(C)nc(C(=O)O)n1-c1cccc(C#N)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.53
F11 P03951 1/20 0.46
GRIA2 P42262 1/20 0.43
GRIA4 P48058 1/20 0.43
PIN1 Q13526 1/20 0.40
PDE4B Q07343 1/20 0.39
PDE4D Q08499 1/20 0.39
DRD2 P14416 2/20 0.38
MAPK14 Q16539 1/20 0.38
MAT2A P31153 2/20 0.38
LMNA P02545 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CXCR3 P49682 1/20 0.37
DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3837670 0.71 F11 (0.48) NOTUMF11GRIA2GRIA4PIN1
SCHEMBL7239764 0.68 NOTUM (0.46) NOTUMF11GRIA2GRIA4DRD2
SCHEMBL9185196 0.68 GRIA2 (0.42) NOTUMGRIA2GRIA4PIN1ALDH1A1
SCHEMBL29331970 0.68 NOTUM (0.57) NOTUMF11LMNAALDH1A1
SCHEMBL3834637 0.68 F11 (0.52) NOTUMF11PIN1ALDH1A1TP53
SCHEMBL3831431 0.67 NOTUM (0.44) NOTUMF11GRIA2GRIA4DRD2
SCHEMBL3830277 0.66 NOTUM (0.55) NOTUMF11ALDH1A1TP53TSHR
SCHEMBL1680141 0.66 F10 (0.53) NOTUMF11LMNAALDH1A1TP53
SCHEMBL3833545 0.66 GRM5 (0.53) NOTUMALDH1A1TP53
Hydrochloric Acid SCHEMBL3830146 0.65 F10 (0.52) NOTUMF11ALDH1A1TP53TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0946508-B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2009-09-23 EP disclosed
US-6548512-B1 Pyrazole derivatives such as 1-(3-amidinophenyl)-3-methyl-2-((5-(2'-aminosulfonylphenyl-1-yl)pyrimidin-2 -yl)aminocarbonyl)pyrazole; treating thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-04-15 US disclosed
US-6020357-A CARDIOVASCULAR DISORDERS; ANTCOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 2000-02-01 US disclosed
EP-0946508-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-10-06 EP disclosed
WO-1998028269-A1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1998-07-02 WO disclosed